Shares of Alere (NYSE: ALR), a provider of diagnostic tests to the medical community for disease detection, plunged as much as 16% during Friday's trading session after releasing disappointing ...
Finally the much contentious merger of Abbott Laboratories ABT with Alere is nearing its close. As expected, the financial terms of the deal have been amended. Per the amended terms of the agreement, ...
Alere Inc. ALR recently apprised that it has received CLIA waiver from the U.S. Food and Drug Administration (FDA) for its Alere i Strep A test. Additionally, Alere announced an acquisition and a ...
Alere's stock fell 13% on Wednesday after the CEO of suitor Abbott Laboratories' meh comment on its proposed acquisition of Alere. Here's what Miles White said in response to JP Morgan analyst Michael ...
Shares of Alere plunged Friday morning after the company disclosed in a filing that one of its units has seen its Medicare enrollment revoked. The Centers for Medicare & Medicaid Services alleged that ...
Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - Diversified healthcare company Abbott Laboratories on Friday agreed to buy Alere Inc at a lower price than it had ...
, an Alere subsidiary specializing in analytics and clinical decision support (CDS) technology, today announced the launch of its Clinical Surveillance product for hospitals, which is an automated ...
Federal criminal investigators have opened a new front in a probe of diagnostic testing company Alere, according to a new report that comes as the firm continues trying to sell itself to in a ...
Alere agreed to pay $33.2 million to resolve False Claims Act allegations that it knowingly sold defective point-of-care diagnostic testing devices. Here are five insights. 1. The U.S. Justice ...
What: Shares of Alere (NYSE: ALR), a pioneer of quick, point-of-care diagnostics, sank by 22.9% in April, according to data from S&P Global Market Intelligence. All it took was an off-the-cuff comment ...
The FDA greenlighted Alere's rapid influenza diagnostic test, which detects influenza A and B infection in adults and children in as few as five minutes. The Alere i Influenza A & B 2 test is a second ...
North suburban-based Abbott Laboratories is making up with Alere after nearly a year of fighting, agreeing to buy the Massachusetts-based company for a lower price and ending its legal battles over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results